Suppr超能文献

成年早期的体重指数与 DNA 错配修复基因突变携带者和非携带者的结直肠癌风险。

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes.

机构信息

Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne School of Population Health, Level 3, 207 Bouverie Street, Parkville, Victoria 3010, Australia.

出版信息

Br J Cancer. 2011 Jun 28;105(1):162-9. doi: 10.1038/bjc.2011.172. Epub 2011 May 10.

Abstract

BACKGROUND

Carriers of germline mutations in DNA mismatch repair (MMR) genes have a high risk of colorectal cancer (CRC), but the modifiers of this risk are not well established. We estimated an association between body mass index (BMI) in early adulthood and subsequent risk of CRC for carriers and, as a comparison, estimated the association for non-carriers.

METHODS

A weighted Cox regression was used to analyse height and weight at 20 years reported by 1324 carriers of MMR gene mutations (500 MLH1, 648 MSH2, 117 MSH6 and 59 PMS2) and 1219 non-carriers from the Colon Cancer Family Registry.

RESULTS

During 122,304 person-years of observation, we observed diagnoses of CRC for 659 carriers (50%) and 36 non-carriers (3%). For carriers, the risk of CRC increased by 30% for each 5 kg m(-2) increment in BMI in early adulthood (hazard ratio, HR: 1.30; 95% confidence interval, CI: 1.08-1.58; P=0.01), and increased by 64% for non-carriers (HR: 1.64; 95% CI: 1.02-2.64; P=0.04) after adjusting for sex, country, cigarette smoking and alcohol drinking (and the MMR gene that was mutated in carriers). The difference in HRs for carriers and non-carriers was not statistically significant (P=0.50). For MLH1 and PMS2 (MutLα heterodimer) mutation carriers combined, the corresponding increase was 36% (HR: 1.36; 95% CI: 1.05-1.76; P=0.02). For MSH2 and MSH6 (MutSα heterodimer) mutation carriers combined, the HR was 1.26 (95% CI: 0.96-1.65; P=0.09). There was no significant difference between the HRs for MutLα and MutSα heterodimer carriers (P=0.56).

CONCLUSION

Body mass index in early adulthood is positively associated with risk of CRC for MMR gene mutation carriers and non-carriers.

摘要

背景

携带 DNA 错配修复(MMR)基因突变的个体发生结直肠癌(CRC)的风险较高,但该风险的修饰因素尚未明确。我们评估了年轻时的体重指数(BMI)与 MMR 基因突变携带者(500 例 MLH1、648 例 MSH2、117 例 MSH6 和 59 例 PMS2)随后发生 CRC 的风险之间的关联,并作为比较,评估了非携带者的关联。

方法

使用加权 Cox 回归分析了来自结肠癌家族登记处的 1324 名 MMR 基因突变携带者(500 例 MLH1、648 例 MSH2、117 例 MSH6 和 59 例 PMS2)和 1219 名非携带者在 20 岁时报告的身高和体重。

结果

在 122304 人年的观察期间,我们观察到 659 名携带者(50%)和 36 名非携带者(3%)发生 CRC。对于携带者,年轻时 BMI 每增加 5kg/m²,CRC 风险增加 30%(风险比,HR:1.30;95%置信区间,CI:1.08-1.58;P=0.01),非携带者增加 64%(HR:1.64;95% CI:1.02-2.64;P=0.04),校正性别、国家、吸烟和饮酒(以及携带者突变的 MMR 基因)后。携带者和非携带者的 HR 差异无统计学意义(P=0.50)。对于 MLH1 和 PMS2(MutLα 异二聚体)突变携带者,相应的增幅为 36%(HR:1.36;95% CI:1.05-1.76;P=0.02)。对于 MSH2 和 MSH6(MutSα 异二聚体)突变携带者,HR 为 1.26(95% CI:0.96-1.65;P=0.09)。MutLα 和 MutSα 异二聚体携带者的 HR 无显著差异(P=0.56)。

结论

年轻时的 BMI 与 MMR 基因突变携带者和非携带者 CRC 的风险呈正相关。

相似文献

引用本文的文献

8
Lynch syndrome: from detection to treatment.林奇综合征:从检测到治疗
Front Oncol. 2023 May 1;13:1166238. doi: 10.3389/fonc.2023.1166238. eCollection 2023.
9
Body mass index and molecular subtypes of colorectal cancer.体重指数与结直肠癌的分子亚型。
J Natl Cancer Inst. 2023 Feb 8;115(2):165-173. doi: 10.1093/jnci/djac215.

本文引用的文献

6
Risks of Lynch syndrome cancers for MSH6 mutation carriers.MSH6 突变携带者的林奇综合征癌症风险。
J Natl Cancer Inst. 2010 Feb 3;102(3):193-201. doi: 10.1093/jnci/djp473. Epub 2009 Dec 22.
10
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.因种系PMS2突变导致的林奇综合征的临床表型。
Gastroenterology. 2008 Aug;135(2):419-28. doi: 10.1053/j.gastro.2008.04.026. Epub 2008 May 2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验